8EQ.F CYTEK BIOSCIENCES DL-001

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
5.10 EUR
Close of Nov 11, 2026
2.82 5.60
Market cap
EUR 667M
P/E
-
P/B
2.37x
ROE
-15.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 8EQ.F undervalued?

Graham number

The Graham number of CYTEK BIOSCIENCES DL-001 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

CYTEK BIOSCIENCES DL-001 fundamental analysis

No fundamental analysis for CYTEK BIOSCIENCES DL-001 yet.

CYTEK BIOSCIENCES DL-001 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About CYTEK BIOSCIENCES DL-001

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagest…

Full company profile